Clinical Trial Update: Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy [Phase 2]

View source ↗

Summary

Phase 2 study of ARI-0001 CAR-T cells for CD19-positive acute lymphoblastic leukemia. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• ARI-0001 CAR-T cells (CAR-T cell therapy targeting CD19)

Snippet

Sponsor: Sara V. Latorre | Conditions: Acute Lymphoid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING